+ Filter
Loading...
MET & EGFR
Loading...Anti-MET & EGFR Products
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
-
- Target: EGFR
- Species Reactivity: Human
- Cytokine 1: IL2
- Host: Mouse
- Cytokine 1 Species: Human
- Molecule Class: IL2-IgG2a
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, WB
-
- Derivation: Chimeric
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: FuncS, IF, Neut, ELISA, FC, IP, IHC
-
- Derivation: Humanized (from rat)
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: Neut, ELISA, IF, IP, FuncS, FC, WB
-
- Derivation: Human
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: FC, IP, ELISA, Neut, FuncS, IF, WB
- Anti-Human Met(Onartuzumab) (TAB-190-F(E))
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: Fab / Fc - G1 - kappa
- Application: IP, IF, FuncS, FC, Neut, ELISA, ICC
- Anti-Human MET Recombinant Antibody (TAB-521CL) (TAB-521CL)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Antibody
- Application: WB, FuncS
-
- Derivation: Human
- Species Reactivity: Human
- Type: IgG2 - kappa
- Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: ELISA, IP, FC, FuncS, Neut, IF, IHC
-
- Derivation: Human
- Species Reactivity: Human
- Type: Human IgG
- Application: WB, Block, FuncS
- Anti-Human EGFR Recombinant Antibody (ABT-806) (TAB-228CL)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Antibody
- Application: WB, IHC
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: WB
- Anti-Human MET Recombinant Antibody (TAB-0530CL)
-
- Application: ELISA, FC, IF, FuncS
- Anti-Human MET Recombinant Antibody scFv Fragment (TAB-0530CL-S(P))
-
- Application: ELISA, FC, IF, FuncS
- Human Anti-EGFR Recombinant Antibody (TAB-270MZ) (TAB-270MZ)
-
- Species Reactivity: Human
- Type: Human antibody
- Application: ELISA
- Human Anti-EGFR Recombinant Antibody; scFv Fragment (TAB-270MZ-S(P)) (TAB-270MZ-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA
- Human Anti-EGFR Recombinant Antibody; scFv Fragment (TAB-274MZ-S(P)) (TAB-274MZ-S(P))
-
- Species Reactivity: Human
- Type: Humanized scFv
- Application: FC
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: IgG4 - kappa
- Application: FuncS, IF, Neut, ELISA, FC, IP, WB
-
- Derivation: Human
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
-
- Derivation: Chimeric (Human/Mouse)
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: Neut, ELISA, IF, IP, FuncS, FC, WB
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1, κ
- Application: WB, ELISA, FC, IF, IHC, FuncS
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: IgG1
- Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
-
- Derivation: Chimeric (human/mouse)
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: IF, WB, Inhib
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: ADCC enhanced antibody
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: ADCC enhanced antibody
- Rabbit Anti-Human EGFR (phospho Y1092) Antibody (MOB-0242MC)
-
- Species Reactivity: Rat, Human
- Application: IHC, WB
- Rabbit Anti-Human EGFR (phospho Y1068) Antibody (MOB-0243MC)
-
- Species Reactivity: Human, Mouse, Rat
- Application: IHC, WB
-
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA, WB, FuncS
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: FC
-
- Species Reactivity: Human
- Type: Human IgG
- Application: FC
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA, WB
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, WB
- Human Anti-MET Recombinant Antibody; Fab Fragment (TAB-0332CL-F(E)) (TAB-0332CL-F(E))
-
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA
- Anti-Human EGFR Recombinant Antibody scFv Fragment (DX 1-10) (TAB-323MZ-S(P))
-
- Type: Human antibody
- Application: SPR
- Anti-Human EGFR Recombinant Antibody scFv Fragment (pSEX81-6) (TAB-324MZ-S(P))
-
- Derivation: Phage display library
- Type: Human antibody
- Application: IP, ELISA, FC
- Anti-Human EGFR Recombinant Antibody scFv Fragment (pSEX81-63) (TAB-325MZ-S(P))
-
- Derivation: Phage display library
- Type: Human antibody
- Application: IP, ELISA, FC
- Mouse Anti-EGFR Recombinant Antibody; scFv Fragment (TAB-272MZ-S(P)) (TAB-272MZ-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: FuncS
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) IgG
- Application: FuncS
-
- Species Reactivity: Human
- Type: Human IgG
- Application: Block
- Human Anti-EGFR Recombinant Antibody (TAB-0225CL) (TAB-0225CL)
-
- Derivation: Chimeric (Mouse/Human)
- Species Reactivity: Human
- Type: Chimeric (Mouse/Human) IgG1
- Application: Block, Inhib, FuncS, Apop, In vivo
- Anti-Human MET Recombinant Antibody Fab Fragment (TAB-0530CL-F(E))
-
- Application: ELISA, FC, IF, FuncS
- Human Anti-EGFR Recombinant Antibody; scFv Fragment (TAB-0225CL-S(P)) (TAB-0225CL-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: Block, Inhib, FuncS, Apop, In vivo
- Human Anti-MET Recombinant Antibody; scFv Fragment (TAB-025MZ-S(P)) (TAB-025MZ-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, FC
- Anti-Human MET Recombinant Antibody scFv Fragment (73R009) (TAB-026MZ-S(P))
-
- Type: Humanized antibody
- Application: WB
- Mouse Anti-EGFR Recombinant Antibody; Fab Fragment (TAB-0564CL-F(E)) (TAB-0564CL-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA
- Mouse Anti-EGFR Recombinant Antibody; Fab Fragment (TAB-0565CL-F(E)) (TAB-0565CL-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, Neut
- Mouse Anti-EGFR Recombinant Antibody; scFv Fragment (TAB-273MZ-S(P)) (TAB-273MZ-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: FC
-
- Scaffold Name: Z-domain of protein A
- Target: EGFR
- Species Reactivity: Human
- Derivation: Phage display
-
- Derivation: Llama
- Species Reactivity: Human
- Type: Llama VHH
- Application: WB, ELISA
-
- Derivation: Llama
- Species Reactivity: Human
- Type: Llama VHH
- Application: FuncS, ELISA, IF
-
- Derivation: Llama
- Species Reactivity: Human
- Type: Llama VHH
- Application: FuncS, SPR
-
- Species Reactivity: Human
- Type: Human scFv
- Application: FC
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: ELISA, WB, FuncS
-
- Derivation: Human
- Species Reactivity: Human
- Type: Human scFv
- Application: WB, Block, FuncS
-
- Derivation: Human
- Species Reactivity: Human
- Type: Human Fab
- Application: WB, Block, FuncS
-
- Species Reactivity: Mouse
- Type: Llama VHH
- Application: ELISA, IHC, FC, FuncS
- Anti-MET immunotoxin (Fab)-PE (AGTO-G049E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Mouse Anti-EGFR Recombinant Antibody; scFv Fragment (TAB-275MZ-S(P)) (TAB-275MZ-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: FC
- Anti-Human EGFR Recombinant Antibody scFv Fragment (LA1) (TAB-276MZ-S(P))
-
- Application: MTT assay
- Anti-Human EGFR Recombinant Antibody scFv Fragment (LA22) (TAB-277MZ-S(P))
-
- Application: MTT assay
- Mouse Anti-EGFR Recombinant Antibody; scFv Fragment (TAB-271MZ-S(P)) (TAB-271MZ-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: FuncS
- Anti-EGFR Antibody-Cytokine Fusion Protein, IgG-IL2 (ACFP-SH155)
-
- Target: EGFR
- Species Reactivity: Human
- Cytokine 1: IL2
- Host: Humanized from Mouse
- Cytokine 1 Species: Human
- Molecule Class: IgG1-IL2
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, WB, FuncS
- Mouse Anti-EGFR Recombinant Antibody; scFv Fragment (TAB-0564CL-S(P)) (TAB-0564CL-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA
- Mouse Anti-EGFR Recombinant Antibody (TAB-0565CL) (TAB-0565CL)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA
- Mouse Anti-MET Recombinant Antibody (TAB-534LC) (TAB-534LC)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: FC, FuncS, Inhib
- Mouse Anti-EGFR Recombinant Antibody (TAB-0564CL) (TAB-0564CL)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA
-
- Species Reactivity: Human
- Type: Human scFv
- Application: Block
-
- Target: EGFR
- Species Reactivity: Human
- Cytokine 1: IL2
- Host: Chimeric (Mouse-Human)
- Cytokine 1 Species: Human
- Molecule Class: IgG-IL2
-
- Target: EGFR
- Species Reactivity: Human
- Cytokine 1: TNFα
- Host: Mouse
- Cytokine 1 Species: Human
- Molecule Class: TNF-IgG2a
- 10-FnIII scaffold protein anti-Human EGFR (SFN-L003)
-
- Scaffold Name: 10-FnIII
- Target: EGFR
- Species Reactivity: Human
- Derivation: Phage display
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: FC
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: Block
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: FC
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) Fab
- Application: FuncS
-
- Species Reactivity: Human
- Type: Human Fab
- Application: Block
- Anti-EGFR-doxorubicin ADC (ADC-168LZY)
-
- Target: EGFR
- Linker: polyethylene glycol linker
- Drug: doxorubicin
- Anti-EGFR (clone J2898A)-SMCC-DM1 ADC (ADC-047LZY)
-
- Target: EGFR
- Linker: SMCC (N-succinimidyl-4-(N-maleimidomethyl)-cyclohexane-1-carboxylate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-EGFR-MCC-Dox ADC (ADC-057LZY)
-
- Target: EGFR
- Linker: MCC (4-(N-maleimidomethyl)cyclohexane-1-carboxylate)
- Drug: doxorubicin
- Anti-EGFR-EDC/NHS-Dox ADC (ADC-058LZY)
-
- Target: EGFR
- Linker: EDC/NHS(1-ethyl-3-(3-diaminopropyl)carbodiimide/N-hydroxysuccinimide)
- Drug: doxorubicin
- Anti-EGFR-SMCC-methotrexate ADC (ADC-059LZY)
-
- Target: EGFR
- Linker: SMCC (N-succinimidyl-4-(N-maleimidomethyl)-cyclohexane-1-carboxylate)
- Drug: MTX
- Anti-EGFR-EDC/NHS-methotrexate ADC (ADC-060LZY)
-
- Target: EGFR
- Linker: EDC/NHS
- Drug: MTX
- Anti-EGFR (clone ABT-806)-mc-MMAF ADC (ADC-071LZY)
-
- Target: EGFR
- Linker: mc (maleimidocaproyl)
- Drug: MMAF (monomethyl auristatin F)
- Anti-EGFR-vc-Duostatin-3 ADC (ADC-088LZY)
-
- Target: EGFR
- Linker: VC (valine-citrulline)
- Drug: Duostatin-3
- Anti-EGFRvIII-SMCC-DM1 ADC (ADC-048LZY)
-
- Target: EGFRvIII
- Linker: SMCC (N-succinimidyl-4-(N-maleimidomethyl)-cyclohexane-1-carboxylate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-EGFR (ABT-806)-Mc-MMAE ADC (ABT-414) (ADC-L001)
-
- Target: EGFR
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Cetuximab (Gly-015CL)
-
- CAS number: 205923-56-4
-
- Targets: MET & EGFR
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
- Anti-EGFR-MC-VC-PABA-MMAE ADC (ADC-037CL)
-
- Target: EGFR
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-EGFR-MC-VC-PABA-MMAE ADC (ADC-038CL)
-
- Target: EGFR
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-EGFR-mc-MMAF ADC (ADC-039CL)
-
- Target: EGFR
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-EGFR (clone Bat0206)-S-3AA-MDC ADC (ADC-157CL)
-
- Target: EGFR
- Linker: S-3AA
- Drug: MDC (maytansinol)
- Anti-EGFR (clone Bat0206)-SMCC-MDC ADC (ADC-158CL)
-
- Target: EGFR
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: MDC (maytansinol)
- Anti-EGFR (clone Antibody 1)-MC-MMAF ADC (ADC-059CL)
-
- Target: EGFR
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-EGFR-vc-PAB-MODO ADC (ADC-263CL)
-
- Target: epidermal growth factor receptor (EGFR)
- Linker: VC-PAB (valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MODO (monomethyldolastatin)
- Anti-EGFR-Mal-dPEG4-NHS-DM1 ADC (ADC-107LCT)
-
- Target: EGFR
- Linker: Mal-dPEG4-NHS
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-EGFR (MAb806)-Mc-MMAF ADC (ADC-109LCT)
-
- Target: EGFR
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-EGFR (MAb806)-SMCC-DM1 ADC (ADC-110LCT)
-
- Target: EGFR variant III
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
View More Products
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
This gene encodes a member of the receptor tyrosine kinase family of proteins and the product of the proto-oncogene MET. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that are linked via disulfide bonds to form the mature receptor. Further processing of the beta subunit results in the formation of the M10 peptide, which has been shown to reduce lung fibrosis. Binding of its ligand, hepatocyte growth factor, induces dimerization and activation of the receptor, which plays a role in cellular survival, embryogenesis, and cellular migration and invasion. Mutations in this gene are associated with papillary renal cell carcinoma, hepatocellular carcinoma, and various head and neck cancers. Amplification and overexpression of this gene are also associated with multiple human cancers.
Receptor for EGF, but also for other members of the EGF family, as TGF-alpha, amphiregulin, betacellulin, heparin-binding EGF-like growth factor, GP30 and vaccinia virus growth factor. Is involved in the control of cell growth and differentiation. Phosphorylates MUC1 in breast cancer cells and increases the interaction of MUC1 with SRC and CTNNB1/beta-catenin. Isoform 2 may act as an antagonist of EGF action.


Bladder Cancer
EGFR Tyrosine Kinase Inhibitor Resistance
Non-small Cell Lung Cancer
Pancreatic Cancer
Hepatocellular Carcinoma
Cushing Syndrome
JAK-STAT Signaling Pathway
